Alpha-1 antitrypsin protein and gene therapies decrease autoimmunity and delay arthritis development in mouse model
<p>Abstract</p> <p>Background</p> <p>Alpha-1 antitrypsin (AAT) is a multi-functional protein that has anti-inflammatory and tissue protective properties. We previously reported that human AAT (hAAT) gene therapy prevented autoimmune diabetes in non-obese diabetic (NOD)...
Main Authors: | Atkinson Mark A, Satoh Minoru, Wasserfall Clive H, Choi Young-Kook, Grimstein Christian, Brantly Mark L, Campbell-Thompson Martha, Song Sihong |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-02-01
|
Series: | Journal of Translational Medicine |
Online Access: | http://www.translational-medicine.com/content/9/1/21 |
Similar Items
-
Lung Inflammation in alpha-1-antitrypsin deficient individuals with normal lung function
by: Nurdan Kokturk, et al.
Published: (2023-02-01) -
Development of a risk score to increase detection of severe alpha-1 antitrypsin deficiency
by: E. Leonard Riley, et al.
Published: (2023-09-01) -
Detection of alpha-1 antitrypsin deficiency: the past, present and future
by: Mark Brantly, et al.
Published: (2020-04-01) -
The Mechanism of Mitochondrial Injury in Alpha-1 Antitrypsin Deficiency Mediated Liver Disease
by: Nazli Khodayari, et al.
Published: (2021-12-01) -
Decrease in alpha-1 antiproteinase antitrypsin is observed in primary Sjogren’s syndrome condition
by: Brij B. Singh, et al.
Published: (2020-07-01)